VENTYX BIOSCIENCES
Ventyx Biosciences is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. Ventyx’s clinical stage pipeline includes VTX958, a Phase 1 allosteric TYK2 inhibitor for the treatment of a broad range of autoimmune diseases, VTX002, a Phase 2-ready S1P1 receptor modulator for the treatment of ulcerative colitis, and VTX2735, a Phase 1 peripheral inhibitor of the NLRP3 inflammasome, which is a mediator of multiple inflammatory conditions.
VENTYX BIOSCIENCES
Social Links:
Industry:
Biopharma Biotechnology
Founded:
2018-01-01
Address:
Encinitas, California, United States
Country:
United States
Website Url:
http://www.ventyxbio.com
Total Employee:
51+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
441.6 M USD
Technology used in webpage:
Euro Google Maps IPv6 COVID-19 Akamai Hosted
Similar Organizations
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
EpiVario
EpiVario develops novel compounds to treat memory-related psychiatric disorders at the source of the disease.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Harmony Biosciences
Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.
Innovent Biologics
Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Halo Labs
Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Redmile Group
Redmile Group investment in Post-IPO Equity - Ventyx Biosciences
Surveyor Capital
Surveyor Capital investment in Post-IPO Equity - Ventyx Biosciences
Farallon Capital Management
Farallon Capital Management investment in Post-IPO Equity - Ventyx Biosciences
Cormorant Asset Management
Cormorant Asset Management investment in Post-IPO Equity - Ventyx Biosciences
EcoR1 Capital
EcoR1 Capital investment in Post-IPO Equity - Ventyx Biosciences
CaaS Capital Management
CaaS Capital Management investment in Post-IPO Equity - Ventyx Biosciences
Acuta Capital Partners
Acuta Capital Partners investment in Post-IPO Equity - Ventyx Biosciences
Boxer Capital
Boxer Capital investment in Post-IPO Equity - Ventyx Biosciences
Redmile Group
Redmile Group investment in Post-IPO Equity - Ventyx Biosciences
Logos Capital
Logos Capital investment in Post-IPO Equity - Ventyx Biosciences
Key Employee Changes
| Date | New article |
|---|---|
| 2024-05-16 | Ventyx Biosciences gets new operations chief |
| 2022-05-09 | Ventyx Biosciences Announces Appointment of William Sandborn, MD, as President and Chief Medical Officer |
Official Site Inspections
http://www.ventyxbio.com Semrush global rank: 3.56 M Semrush visits lastest month: 3.67 K
- Host name: 151.101.66.159
- IP address: 151.101.66.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Ventyx Biosciences"
About Us – Ventyx Biosciences
Most recently, Don was a Senior Vice President in R&D at Allergan where he led an organization responsible for research and preclinical functions, clinical pharmacology, and the scientific arm of business development, while also co …See details»
Ventyx Biosciences – We selectively modulate key …
Feb 18, 2025 We focus on autoimmune, inflammatory, and neurodegenerative diseases with high unmet need. Ventyx Biosciences is a clinical-stage biopharmaceutical company developing innovative oral therapies for patients …See details»
Ventyx Biosciences - Crunchbase Company Profile
Contact Email [email protected] Ventyx Biosciences is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions …See details»
Governance – Ventyx Biosciences
The Board of Directors of Ventyx Biosciences, Inc. (the “Company”) sets high standards for the Company’s employees, officers and directors.See details»
SEC Filings - Ventyx Biosciences, Inc.
The Investor Relations website contains information about Ventyx Biosciences, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
Ventyx Biosciences - 2025 Company Profile - Tracxn
2 days ago Ventyx Biosciences has raised a total funding of $165M over 4 rounds. Its first funding round was on Mar 09, 2021. Its latest funding round was a Post IPO round on Sep 23, …See details»
Ventyx Biosciences Company Profile - Office Locations ... - Craft
Oct 29, 2024 Ventyx Biosciences is a biopharmaceutical company that develops oral medicines for autoimmune and inflammatory disorders. It offers VTX958, an oral, selective clinical-stage …See details»
Ventyx Biosciences Information - RocketReach
Ventyxbio.com; gmail.com; 1 619358XXXX; Roy Gonzales Principal Financial Officer and Principal Accounting Officer at Ventyx Biosciences San Diego, CA, US View. 2 ventyxbio.com; …See details»
Ventyx Biosciences - Overview, News & Similar companies
Jun 20, 2024 Ventyx Biosciences contact info: Phone number: (760) 593-4832 Website: www.ventyxbio.com What does Ventyx Biosciences do? Ventyx Biosciences, Inc., found in …See details»
Ventyx Biosciences Expands SAB with Renowned NLRP3 Experts …
4 days ago For more information on Ventyx, please visit our website at https://ventyxbio.com or on LinkedIn. Forward-Looking Statements . Ventyx cautions you that statements contained in …See details»
Ventyx Biosciences - VentureRadar
Auto Analyst Score: 68 | ventyxbio.com. VentureRadar Popularity. High. VentureRadar Popularity: High. The popularity score combines profile views, clicks and the number of times the …See details»
Investors – Ventyx Biosciences
May 23, 2024 Investors & News We are a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and …See details»
Ventyx Biosciences Company Overview, Contact Details
Strategic Investments Ventyx Biosciences secured a $27 million strategic investment from Sanofi Pasteur Inc., a significant funding boost indicating strong external interest in the company's …See details»
Ventyx Biosciences Raises $114 Million Financing led by venBio …
Mar 9, 2021 [email protected]. Investor Relations and Media Contact. Juniper Point Amy Conrad (858) 914-1962 [email protected].See details»
Ventyx Biosciences Inc. - Cruelty Free Investing
Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead …See details»
Ventyx Biosciences Expands SAB with Renowned NLRP3 Experts …
4 days ago Ventyx’s Expanded Scientific Advisory Board Members :. NLRP3 and the Inflammasome: Mo Lamkanfi, PhD , is a Full Professor of Medical Immunology and Director of …See details»
Ventyx Biosciences Raises $114 Million Financing led by venBio …
ENCINITAS, Calif., March 9, 2021 /PRNewswire/ -- Ventyx Biosciences, Inc. ("Ventyx"), a clinical-stage biotechnology company advancing a pipeline of immune modulators to treat …See details»
Analyzing the Rise and Fall of Ventyx’s Primary Candidate
Apr 28, 2024 Ventyx is a clinical-stage immunology biotech company with candidates for Crohn's disease, ulcerative colitis, and cardiovascular disease. In March 2023, Ventyx boasted a …See details»
Ventyx Biosciences Announces $27 Million Strategic Investment …
Sep 23, 2024 Sanofi to receive an exclusive right of first negotiation for Ventyx’s CNS-penetrant NLRP3 inhibitor VTX3232. SAN DIEGO, Sept. 23, 2024 (GLOBE NEWSWIRE) — Ventyx …See details»
How Does Ventyx Biosciences Work? – CanvasBusinessModel.com
Dec 19, 2024 Website: https://www.ventyxbio.com; Focus: Advancing oral therapies for autoimmune and inflammatory disorders; Through strategic partnerships, clinical trials, and …See details»